Product
Supplier
Encyclopedia
Inquiry
Home > Pharmaceutical Intermediates > Bulk Drug Intermediates > Selank peptide for Sale > High quality MOTS-c (Human) Acetate 99% Powder peptide door to door
High quality MOTS-c (Human) Acetate 99% Powder  peptide door to door buy - large image1
High quality MOTS-c (Human) Acetate 99% Powder  peptide door to door buy - image1
High quality MOTS-c (Human) Acetate 99% Powder  peptide door to door buy - image2
High quality MOTS-c (Human) Acetate 99% Powder  peptide door to door buy - image3
High quality MOTS-c (Human) Acetate 99% Powder  peptide door to door buy - image4

High quality MOTS-c (Human) Acetate 99% Powder peptide door to door

COA 36 Inquiries

Unit Price: Get Latest Price
CAS No.:

129954-34-3

Grade:

Pharmaceutical Grade

Content:

99%

Port:

Tianjin

Brand:

aobosi

Packaging:

10vials/box

Price valid (until):

2026-08-01

Company Type:
Trader
Location:
China
Payment Terms:
TT against copy of documents,D/P,L/C,D/A,O/A,TT against B/L draft before shipment,100% TT in advance
Average Lead Time:
7 days
Qualification:
Main Products:

peptide

  • Product Description

  • Seller Information

  • Inquiry History

  • Description


      Product Detail  


    What is Retatrutide?


    Retatrutide is a triple glucagon, GIP, and receptor agonist. Retatrutide showed glucose control and weight loss in patients with type 2 diabetes mellitus (T2DM).Retatrutide (LY3437943) is a triple agonist peptide of the glucagon receptor (GCGR), glucosedependent insulinotropic polypeptide receptor (GIPR), and glucagon-like peptide-1 receptor . Retatrutide can be used for the research of obesity.Normally, this peptide will be delivered in lyophilized form and should be stored in a freezer at or below -20 °C. For more details, please refer to the manual:Handling and Storage of Synthetic Peptides. Retatrutide is a new weight loss drug being experimented on by Eli Lilly, a pharmaceutical giant renowned for its breakthrough in diabetes and obesity treatment. Much like other weight loss drugs rolled out by Eli Lilly, Retatrutide is administered under the skin (subcutaneous route) per week and has yielded exceptional results in treating chronic diseases like diabetes and obesity compared to the predecessors.

    Function

    1. 1.Treatment of depression and anxiety disorders:  Retatrutide has been shown to have antidepressant and anxiolytic effects in preclinical studies, suggesting that it could be a promising treatment option for individuals with these conditions.
    2. 2.Prevention of neurodegenerative diseases:  Retatrutide  has neuroprotective properties that may be useful in preventing or slowing the progression of neurodegenerative diseases such as Alzheimer's and Parkinson's.
    3. 3.Enhancement of cognitive function:  Retatrutide has been shown to improve learning and memory in animal studies, suggesting that it could have potential as a cognitive enhancer in humans.
    4. 4.Treatment of chronic pain: Retatrutide has been shown to have analgesic effects in preclinical studies, suggesting that it could be a useful treatment option for individuals with chronic pain conditions.
    5. 5.Promotion of wound healing:  Retatrutide  has been shown to accelerate wound healing in animal studies, suggesting that it could have potential as a therapeutic agent for promoting wound healing in humans.

    Application

    1. Retatrutide is often used in the pharmaceutical industry, weight losing, etc.
    2. Retatrutide is a kind of peptide product.
    3. Retatrutide acetate can inhibited GCGR, GIPR and GLP-1R.
    4. Retatrutide acetate is activated by glucagon receptors resulting in significant weight loss and increased energy expenditure.
    5. Retatrutide acetate can be used in studies of obesity.

    Shop High quality MOTS-c (Human) Acetate 99% Powder  peptide door to door-Detailed Image 1
    ECHEMI Editorial Reference
    Selank is a synthetic derivative of the tetrapeptide tuftsin that contains a proline-glycine-proline sequence at the C-terminus and has anxiolytic and anti-inflammatory activities. It increases the amplitude and discharge rate of inhibitory postsynaptic currents of neurons in the rat hippocampal CA1 region when used at a concentration of 1 μM. It decreases the level of affective responses and the number of erroneous escape attempts in rats in an acute stress situation, increases orientational-investigative responses of rats in an unfamiliar situation, and reduces the time mice spend immobile in the forced swim test. It increases locomotor activity of high-anxiety Balb/c, but not C57Bl/6, mice in the open field test. Selank (0.01 mg/kg) decreases verticalization induced by apomorphine in mice. It also decreases expression of the inflammation-related genesIl2rgandXcr1in mouse spleen after 90 minutes when administered at a dose of 100 μg/kg.
    SELANK Synthetic is a single, non-glycosylated polypeptide chain containing 7 amino acids, having a molecular mass of 751.89  Dalton and a Molecular formula of C33H57N11O9.

    Certificates

    Basic Info
    Product Name:

    Selank peptide

    Other Name:

    Selank peptide;SelankAcetate;PL14736;L-threonyl-L-lysyl-L-prolyl-L-arginyl-L-prolylglycyl-L-proline;L-THREONYL-L-LYSYL-L-PROLYL-L-ARGINYL-L-PROLYLGLYCYL-L-PROLINE; MONOACETATE;H-Thr-Lys-Pro-Arg-Pro-Gly-Pro-OH;SLANK;Selank peptid

    CAS No.:

    129954-34-3

    Molecular Formula:

    C33H57N11O9

    InChIKeys:

    JTDTXGMXNXBGBZ-YVHUGQOKSA-N

    Molecular Weight:

    751.87

    Exact Mass:

    751.43407244

    EC Number:

    232-660-2

    UNII:

    TS9JR8EP1G

    Characteristics
    Density:

    1.53±0.1 g/cm3(Predicted)

    Melting Point:

    134-136 °C

    PKA:

    3.43±0.20(Predicted)

    Research
    Class:

    Mitochondrial-derived peptide (MDP), 16-amino-acid peptide

    Status:

    Research compound — Not FDA approved

    Mechanism:

    MOTS-c (mitochondrial ORF of the twelve S rRNA-c) is a 16-amino-acid peptide encoded by the mitochondrial genome (not nuclear DNA). It is a mitochondrial-derived peptide that regulates metabolic homeostasis by activating the AMPK/PGC-1\u03b1 pathway, improving insulin sensitivity, and enhancing exercise capacity. MOTS-c crosses the blood-brain barrier and has been shown to reduce body weight and improve glucose tolerance in preclinical models.

    Activity note:

    MOTS-c does not act via a traditional receptor. It functions as a metabolic regulator, activating AMPK. Functional effects are observed at micromolar concentrations in cell-based assays.

    Source:

    Lee C, et al. Cell Metab. 2015;21(3):443-454. MCE: MOTS-c (CAS 1627580-64-6).DOI

    References
    PubChem:

    PubChem

    Disclaimer:

    MOTS-c is NOT FDA-approved or EMA-approved. It is a research compound only. All data are from preclinical (cell/animal) studies; no human clinical trials have been completed. This listing is for industrial and laboratory research use only. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.

  • Seller Information
    Business Type:

    Trader

    Main Products:

    peptide

    Location:

    Room 1601-1, Building 1, Yuanlun Mansion, No. 350 Qifei Road, Changhe Street, Binjiang District, Hangzhou City, Zhejiang Province, China

    Payment Terms:

    TT against copy of documents,D/P,L/C,D/A,O/A,TT against B/L draft before shipment,100% TT in advance

    Average lead Time:

    7 days

    Total Annual Revenue:

    $1 million-$2.5 million

    Total Employees:

    11-50

    Year of Establishment:

    2026

  • Inquiry History
    36 Inquiries
    Country Product Purchase Quantity Date Posted
    United States

    Selank 99% Purity 129954-34-3

    1 G Jan 23, 2026
    United States

    Selank peptide

    10 MG Sep 18, 2026
    Greece

    selank

    10 MG May 20, 2026
    United States

    N acetyl selank

    500 MG Apr 30, 2026
    United States

    Selank

    100 MG Apr 24, 2026
    Italy

    Nacetyl selank

    1 MT Apr 22, 2026
    Oman

    Selank

    1 G Mar 4, 2026
    United States

    Selank

    30 40' Fcl Oct 14, 2025
    United States

    selank

    30 MG May 25, 2026
    Brazil

    Selank

    10 MT Apr 7, 2026
    United States

    selank

    1 G Mar 13, 2026
    United States

    Selank

    1 G Mar 9, 2026
    United Kingdom

    Selank

    1 G Dec 22, 2025
    United States

    Selank

    20 MG Nov 10, 2025
    United States

    NA-Selank Amidate

    10 MG Sep 18, 2025
    United Kingdom

    Selank

    100 MG Jul 15, 2025
    United States

    N-Acetyl Selank Amidate

    1 KG Jan 9, 2025
    United States

    Selank

    10  Mar 29, 2024
    Poland

    Selank

    10 G Feb 18, 2024
    United States

    Selank

    1 G Jan 27, 2024
    • 1
    • 2
    • Go to Page Go
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.